Evan Sumner is an associate in the Intellectual Property Practice Group in the firm's San Diego (Del Mar) office.
Areas of Practice
Evan focuses his practice on patent litigation, trade secret misappropriation, and intellectual property licensing in the areas of pharmaceuticals, biologics, and medical devices.
Evan is experienced in Hatch-Waxman litigation, and leverages his technical background in pharmacology to effectively represent pharmaceutical companies in complex ANDA cases.
In addition to his litigation experience, Evan is also admitted to the United States Patent and Trademark Office (USPTO) where he files and prosecutes patents directed towards various biomedical and pharmaceutical technologies.
While pursuing his Ph.D., Evan focused his research on preparing and testing various pharmaceutical compositions for the treatment of gastrointestinal cancers. His technical experience includes pharmacology, cellular and molecular biology, chemistry, and drug design.
- Suing for Patent Infringement if the Government Takes Your Intellectual Property During the COVID-19 PandemicIPWatchdog, 04.24.2020
- Law360, 04.21.2020
FDA Law Update Blog Posts
- "April 16 Update: Key FDA Actions for COVID-19 Devices and Therapies," April 16, 2020
- "Update: Key FDA Actions for COVID-19 Devices and Therapies," April 8, 2020
Intellectual Property Law Blog
J.D., University of San Diego, 2019
Ph.D., Pharmacology/Toxicology, VCU Medical School, 2016
B.S., Biology, Virginia Tech, 2010, magna cum laude
- United States Patent and Trademark Office